These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3602446)

  • 21. Ionic and non-ionic contrast agent-mediated endothelial injury. Quantitative analysis of cell proliferation during endothelial repair.
    Gabelmann A; Haberstroh J; Weyrich G
    Acta Radiol; 2001 Jul; 42(4):422-5. PubMed ID: 11442469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hematologic alterations induced by contrast media].
    Elefante R; Violini M; Cirillo S; La Tessa G; Rotondo A; Fucci G; Borgia G; Nappa S; Ruocco A; De Caterina M
    Riv Neurobiol; 1984; 30(2-3):96-108. PubMed ID: 6544512
    [No Abstract]   [Full Text] [Related]  

  • 23. Morphological and functional abnormalities in platelets exposed in vitro to ioglicinic acid, a new ionic contrast medium.
    De Caterina M; Ruocco A; Violini M; Grassi R; Borgia G; Crowell J; Nappa S; di Minno G
    Ric Clin Lab; 1987; 17(2):143-7. PubMed ID: 3629121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of a new water-soluble contrast medium, iodamide 300, in urography and cerebral angiography].
    Corsi M; Tassini T
    Quad Radiol; 1969; 34(3):187-206. PubMed ID: 5362794
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pharmacology of nonionic roentgen contrast media].
    Turnheim K
    Wien Klin Wochenschr; 1986 May; 98(11):333-8. PubMed ID: 3727593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative experimental study of central nervous system tolerability of the administration of iopamidol, metrizamide, ioxitalamate, ioxaglate and iocarmate].
    Cahn J; Borzeix MG; Cahn R
    Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):774-8. PubMed ID: 6670839
    [No Abstract]   [Full Text] [Related]  

  • 27. Contrast media induced pulmonary edema. Comparison of ionic and nonionic agents in an animal model.
    Måre K; Violante M; Zack A
    Invest Radiol; 1984; 19(6):566-9. PubMed ID: 6511265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodynamic changes associated with the intra-arterial injection of contrast media. New toxicity tests and a new experimental contrast medium.
    Hilal SK
    Radiology; 1966 Apr; 86(4):615-33. PubMed ID: 5327191
    [No Abstract]   [Full Text] [Related]  

  • 29. Advantages of non-ionic contrast media in vascular applications.
    Malott JC; Fodor J
    Radiol Technol; 1984; 56(2):95-8. PubMed ID: 6390518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experiences with a new hyperosmolar contrast medium Iopamiro, Bracco in peripheral arteriography].
    Kónya A; Kovács K; Vadon G
    Radiol Diagn (Berl); 1985; 26(2):277-83. PubMed ID: 4011876
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experimental investigations on the effect of dimer-X and amipaque on the central nervous system after their use for cerebral ventriculography (author's transl)].
    Kun M; Papierz W; Romaniuk A; Dobek J; Alwasiak J; Gajewicz M; Grońska J; Kun J
    Pol Przegl Radiol Med Nukl; 1981; 45(6):373-8. PubMed ID: 6981102
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of intravenous contrast media used in urography on the complement system and blood calcium].
    Korzec-Grzegorczyk I
    Pol Tyg Lek; 1989 May 1-8; 44(18-19):423-6. PubMed ID: 2636987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iopamidol for myelography. A clinical trial with a new non-ionic contrast medium.
    Peeters F; van Dongen K; Hekster R; Hoogland P; Thijssen H; Tjian T; Wilmink J; Althuisius H
    Diagn Imaging; 1983; 52(6):313-5. PubMed ID: 6357678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Advances in urologic radiodiagnosis with a newly-developed triiodo contrast medium].
    Hackel WA
    Z Urol Nephrol; 1966 Aug; 59(8):575-84. PubMed ID: 5991577
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative evaluation of the effects of ionic vs non-ionic contrast media on the venous endothelium. Scanning electron microscopic observations.
    Morettin LB
    Radiol Med; 1986 Jun; 72(6 Suppl 1):22-4. PubMed ID: 3726193
    [No Abstract]   [Full Text] [Related]  

  • 36. Tolerance and biochemical pharmacology of iopromide.
    Mützel W; Speck U
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():11-7. PubMed ID: 6195966
    [No Abstract]   [Full Text] [Related]  

  • 37. [Contrast quality of iopamidol in excretory urography. Comparative clinical evaluation at various imaging times].
    Osterhage HR
    Fortschr Med; 1985 Dec; 103(47-48):1105-6. PubMed ID: 4085957
    [No Abstract]   [Full Text] [Related]  

  • 38. [Animal experiment study for evaluation of endothelial damage to the aorta after contrast medium administration by ioxithalamate and iomeprol. Quantitative detection of increased cell proliferation with autoradiography].
    Gabelmann A; Weyrich G; Aurich M; Haberstroh J; Freudenberg N; Langer M
    Rontgenpraxis; 1995 Jan; 48(1):14-7. PubMed ID: 7871436
    [No Abstract]   [Full Text] [Related]  

  • 39. Iopamidol: new preclinical and clinical data.
    Bonati F; Felder E; Tirone P
    Invest Radiol; 1980; 15(6 Suppl):S310-6. PubMed ID: 7203941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacological study of a new angiographic contrast agent. I. Toxicity. Elimination].
    Cheymol G; Guerbet M; Tilly G
    Therapie; 1971; 26(3):595-604. PubMed ID: 5113811
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.